Amlodipine News
Aurobindo receives approval from USFDA for Amlodipine Besylate Tablets
Aurobindo Pharma Ltd has announced that the Company has received approval from the USFDA for Amlodipine Besylate Tablets 2.5 mg, 5 mg & 10 mg. This is the Company's fifth anti-hypertensive approval from USFDA.
Lupin gets USFDA nod for Amlodipine Besylate Tablets
Lupin received approval from the USFDA for it`s Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5 mg (base), 5 mg (base) and 10 mg (base). Commercial shipments of Amlodipine Besylate Tablets will...
Roxane Laboratories announces launch of Amlodipine Besylate tablets
Roxane Laboratories, Inc. has announced the approval of its Abbreviated New Drug Application (ANDA) for Amlodipine Besylate Tablets, 2.5mg, 5mg, and 10mg by the U.S. Food and Drug Administration.
Exforge(R) Receives Final US Approval As New And Powerful Treatment Option For Patients With High Blood Pressure
Exforge(R), a single- tablet combination of two of the most prescribed high blood pressure medicines, has been granted final US Food and Drug Administration approval and is expected to be available soon as an effective treatment...
Ranbaxy receives USFDA nod for Amlodipine Besylate
Country's biggest pharmaceutical firm Ranbaxy Laboratories on Wednesday said it has received tentative US Food and Drug Administration (USFDA) approval to market its anti-hypertension tablets, Amlodipine Besylate, in the US.